Conditions Clinical Trial
Official title:
Use of a Robotic Exoskeleton to Promote Walking Recovery After Stroke - Phase 2
To determine the effect of using a robotic exoskeleton to allow walking practice after stroke, compared to usual physiotherapy care, on recovery of walking ability and secondary outcomes.
Participants admitted to inpatient stroke rehabilitation for physiotherapy services will be
randomly assigned to either the Exoskeleton Program or Usual Care Program.
Individuals in the Exoskeleton Program will have their usual physiotherapy sessions replaced
with the exoskeleton intervention. The exoskeleton will allow standing and walking from the
first sessions in rehabilitation, as the exoskeleton provides the physical support to allow
walking in full weight-bearing without being limited by therapist fatigue and lifting
requirements. Individuals in the Usual Care Program will receive standard physiotherapy care,
which is individualized and hands-on with their therapist to regain walking, mobility, and
independent function.
Both groups will be conducted 3-5 days a week, 30-60 minutes per session until discharge (to
a maximum of 8 weeks). Participants will be assessed at baseline, discharge, and 6-months
after starting rehabilitation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03139175 -
Association Between TMD and LBP Back Pain
|
N/A | |
Recruiting |
NCT03596892 -
Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT
|
Phase 2/Phase 3 | |
Completed |
NCT02189044 -
Pilates and Muscle Strength Respiratory
|
N/A | |
Enrolling by invitation |
NCT05952999 -
Analysis of the Virtual Acute Care at Home Experience
|